Volume Forty-TWO

Benjamin Berkman, J.D., M.P.H.,
Deputy Director and Senior Fellow, the O'Neill Institute for Global and National Law, Georgetown University Law Center

Mr. Berkman received his B.A., magna cum laude, from Harvard University and his J.D. and M.P.H. from the University of Michigan. He studies various issues, such as public health emergency preparedness, bioterrorism, mental health, genetics, and human experimentation. Mr. Berkman has worked for the American Medical Association Ethics Department, ABC News Medical Unit, and the Economic and Social Research Institute. He has also served on an Institute of Medicine committee regarding pandemic influenza preparedness. Mr. Berkman currently works with the World Health Organization and the Centers for Disease Control and Prevention.

http://www.publichealthlaw.net/About/Facstaff.htm

John A. Brennan, M.D.,
Executive Director, Newark Beth Israel Medical Center, an affiliate of the Saint Barnabas Health Care System

Dr. Brennan received his B.S., cum laude, from LeMoyne College, his M.D. from Georgetown University School of Medicine, and he completed his emergency medicine residency at Los Angeles County/University of California Medical Center. He currently oversees the daily operations of the 673-bed teaching hospital, Newark Beth Israel Medical Center. Formerly, he was the Vice President of Emergency Services for the Saint Barnabas Health Care System, and served in other emergency medical services leadership capacities, as well, during his 10 years with the hospital system. Prior to this, Dr. Brennan served as a Major in the Air Force where he was Chief of Emergency Services. Board-certified in both Emergency Medicine and Pediatric Emergency Medicine, Dr. Brennan is a fellow with the American College of Emergency Physicians and the American Academy of Pediatrics. He is the co-author of two textbooks: Pediatric Emergency Medicine (2007) and Principles of EMS Systems, third edition (2006).

Carl H. Coleman, J.D.,
Director of the Health Law & Policy Program and Professor of Law, Seton Hall Law School; former Bioethics and Law Advisor for the World Health Organization

Professor Coleman received his B.S.F.S., cum laude, from Georgetown University and his J.D., magna cum laude, from Harvard Law School. He previously served as Counsel and as the Executive Director of the New York State Task Force on Life and the Law, a group that recommends public policy on bioethical issues. Professor Coleman has also served as a member on several institutional review boards, and as the co-chair of the Committee on Ethical Issues in the Provision of Health Care of the New York State Bar Association. As the former Bioethics and Law Advisor at the World Health Organization in Geneva, Switzerland, he was one of the drafters of the WHO report, Ethical Considerations in Preparing for a Public Health Response to Pandemic Influenza. As a consultant, he continues to work with the WHO on projects related to ethics and public health. He has written various law review articles, including Potential Penalties for Health Care Professionals Who Refuse to Work During a Pandemic and Beyond the Call of Duty: Compelling Health Care Professionals to Work During an Influenza Pandemic (forthcoming).

http://law.shu.edu/faculty/fulltime_faculty/colemaca/coleman.htm

Dennis D. Crouch, J.D.,
Associate Professor, University of Missouri Law School

Professor Crouch received his BSE, cum laude, from Princeton University and his J.D., cum laude, from the University of Chicago Law School. While at the University of Chicago, he was a Microsoft, Merck, & Pfizer scholar. Previously, Professor Crouch was a patent attorney at McDonnell Boehnen Hulbert & Berghoff LLP in Chicago, working on cases involving various technologies. He also taught at Boston University Law School.

http://law.missouri.edu/faculty/crouchd.html

Cynthia M. Ho, J.D.,
Clifford E. Vickrey Research Professor and Director, Intellectual Property and Technology Program, Loyola University of Chicago School of Law

Professor Ho received her B.A. from Boston University and her J.D. from Duke University. She teaches various courses in Policy and Health Care, Intellectual Property, and Patent Law. She has served as a consultant to the United Nations Convention on Biological Diversity and has provided consultation to the National Institutes of Health. Professor Ho has published multiple articles on subjects such as patent issues involving biotechnology and health policy. Her articles include A New World Order for Addressing Patent Rights and Public Health and Inoculation Inventions: The Interplay of Infringement and Immunity in the Development of Biodefense Vaccines. She has spoken at numerous conferences, including presentations such as "Towards a New World Order of Patents and Public Health" and "Patent Law Issues in Biotechnology and Global Health." Prior to teaching, Professor Ho was an associate at Fish & Neave (now the Fish & Neave IP group of Ropes & Gray). Additionally, as a member of the Patent Bar, she drafted and prosecuted patent applications involving medical, immunological, and mechanical inventions.

http://www.luc.edu/law/faculty/ho.html

Adel Mahmoud, M.D., Ph.D.,
Senior Molecular Biologist, Woodrow Wilson School of Public and International Affairs, Princeton University

Professor Mahmoud received his M.D. from the University of Cairo and his Ph.D. from the University of London, School of Hygiene and Tropical Medicine. As the former president of Merck Vaccines, he is considered an expert on disease control. In his position with Merck, he was responsible for the company’s vaccine program that resulted in four new vaccines for rotavirus, HPV, shingles, and a combination vaccine for measles, mumps, rubella, and varicella. He was also responsible for a significant development program for other vaccines, including HIV. Professor Mahmoud has conducted bench research, field investigations, and developed policy recommendations. His research has formed the current global strategy for the control of parasitic infections, which has been adopted by the World Health Organization. He has focused on emerging infections at both the national and global levels, and has developed response policies to deal with microbial resistance, bioterrorism, and containment strategies for pandemic flu. Professor Mahmoud currently serves as a member of the National Science Advisory Board for Biosecurity and CSCANS of the National Academy of Sciences.

http://www.molbio.princeton.edu/index.php?option=com_content&task=view&id=341&Itemid=1

Eileen M. Kane, Ph.D., J.D.,
Associate Professor, Pennsylvania State University Dickinson School of Law

Professor Kane received her B.A. from Hunter College, her Ph.D. from Cornell University, and her J.D. from Fordham University. She teaches a variety of courses that explore the developments in biotechnology, the Internet, and patent law. Her scholarship focuses on biotechnology, including DNA evidence and gene patenting. Professor Kane has published a variety of scientific papers in the Proc. Nat’l Acad. Sci. and the J. Virology, in addition to conducting research at Sloan-Kettering Cancer Center in New York City.

http://www.dsl.psu.edu/faculty/kane.cfm

Alex John London, Ph.D.,
Director, Center for the Advancement of Applied Ethics & Political Philosophy & Associate Professor of Philosophy, Carnegie Mellon University

Professor London received his B.A. from Bard College and his M.A. and Ph.D. from the University of Virginia. His research examines ethical issues in human-subjects research, methodological issues in theoretical and applied ethics, and issues on social justice in the trans-national context. Professor London is the co-editor of Ethical Issues in Modern Medicine: Contemporary Readings in Bioethics, and his publications include Justice in Translation: From Bench to Bedside in the Developing World (forthcoming), and Research in a Public Health Crisis: The Integrative Approach to Managing the Moral Tensions, a paper commissioned by the U.S. Centers for Disease Control and Prevention. He received the New Directions Fellowship from the Andrew W. Mellon Foundation, and more recently, the Distinguished Service Award from the American Society of Bioethics and Humanities.

http://www.hss.cmu.edu/philosophy/faculty-london.php

David Opderbeck, J.D., LL.M.,
Professor of Law, Seton Hall Law School

Professor Opderbeck received his B.A. from Gordon College, his J.D., cum laude, from Seton Hall Law School, and his LL.M. from New York University School of Law. Prior to joining Seton Hall, Professor Opderbeck was a partner in the Intellectual Property / Information Technology Law practice group at McCarter & English, LLP. In his practice, he represented clients in a variety of industries, such as the pharmaceutical industry and information technology. His scholarship focuses on the law, norms, economics, and ethics of information. He has published multiple articles, including Patents, Essential Medicines, and the Innovation Game and A Virtue Ethics Approach to the Biotechnology Commons (or, The Virtuous Penguin).

http://law.shu.edu/faculty/fulltime_faculty/opderbda/opderbda.html

Kevin Outterson, J.D., LL.M.,
Associate Professor of Law, Boston University School of Law

Professor Outterson received his B.S. and J.D. from Northwestern University and his LL.M. from the University of Cambridge. His scholarship focuses on bridging the gap between drug companies and low-income populations to achieve equitable access. He has testified before legislative and regulatory bodies on global pharmaceutical markets, as well as testifying before the US Senate Committee on Health, Education, Labor, & Pensions. Additionally, his work examines health disparities, notably racial and linguistic disparities in health. He has published articles in legal journals, including the Yale J. Health Pol’y L. & Ethics, as well as peer-reviewed medical and health policy journals, such as Health Aff. and Lancet Infectious Diseases.

http://www.bu.edu/law/faculty/profiles/bios/full-time/outterson_k.html

Frank Pasquale, J.D.,
Professor of Law, Assistant Director, the Gibbons Institute of Law, Science & Technology, Seton Hall Law School

Professor Pasquale received his B.A., summa cum laude, from Harvard University, his M.Phil. from Oxford University, and his J.D. from Yale Law School. His scholarship focuses on how economics, philosophy, and social science inform intellectual property and health law. Professor Pasquale has written numerous articles about information law, health law, and politics and jurisprudence. Among the works attributable to him are: The Three Faces of Retainer Care, Two Concepts of Immortality: Reframing Public Debate on Stem Cell Research, and the work in progress entitled Taxing Tiering: Toward the Joint Maximization of Access, Quality, and Cost-Control in Health Care. Additionally, he plans and participates in programs sponsored by Seton Hall Law School’s Health Law & Policy Program and the Gibbons Institute for Law, Science & Technology.

http://law.shu.edu/faculty/fulltime_faculty/pasquafa/pasquale.html

Thomas Pogge, Ph.D.,
Professor, Political Science and Philosophy, Columbia University

Professor Pogge received his Diplom in Soziologie, highest honors, from Hamburg University and his Ph.D. from Harvard University. He is the Professorial Fellow at the Centre for Applied Philosophy and Public Ethics at the Australian National University, Research Director in the Centre for the Study of Mind in Nature at the University of Oslo, and Adjunct Professor in the Centre for Professional Ethics at the University of Central Lancashire. Professor Pogge’s extensive writing on political philosophy has been regarded as one of the most important works on global justice. His focus on negative duties is unique to the dialogue on global justice and eradication of world poverty: the global rich have a negative duty not to contribute to the imposition of an order that prevents the fulfillment of basic socioeconomic rights. He currently works on Incentives for Global Health, an organization dedicated to developing systemic solutions to health challenges faced by the poor. The organization seeks to increase access to medicines by altering the incentives for innovations in the health sector.

http://www.columbia.edu/~tp6/index.html

Paula M. Stannard, J.D.,
Deputy General Counsel, U.S. Department of Health & Human Services

Ms. Stannard graduated magna cum laude from Amherst College with a degree in political science and Latin. She received her J.D. from Stanford Law School and served as an executive editor of the Standford Law Review. Thereafter, she served as a law clerk to the Honorable J.L. Edmondson of the United States Court of Appeals for the Eleventh Circuit. Prior to joining the Department of Health & Human Services, Ms. Stannard was a litigator with Skadden, Arps, Slate, Meagher & Flom in Chicago. In her capacity as Deputy General Counsel at HHS, she advises and counsels HHS policy makers on a variety of legal and policy issues, including public health emergency preparedness and response, the Federal Food, Drug & Cosmetic Act, Medicare Modernization Act implementation, HIPAA Administrative Simplification, medical liability reform (including the Office of General Counsel=s Early Offers Pilot Program), patient safety and the Patient Safety and Quality Improvement Act of 2005, health information technology, the Information Quality Act and the OMB Peer Review Bulletin, limited English proficiency, regulatory reform, compliance with Adarand, abortion, stem cell research, and cloning. Ms. Stannard served as Acting General Counsel of HHS from July 2005 to September 2006.

http://directory.psc.gov/os/1099.html

Antony Taubman, LL.M., B.A., B.Sc.,
Acting Director and Head of the Global Intellectual Property Issues Division, World Intellectual Property Organization

Professor Taubman received his B.Sc. from Sydney, his B.A. from Melbourne, and his LL.M. from Edinburgh. As former Director of the International Intellectual Property Section of the Australian Department of Foreign Affairs and Trade (DFAT), he worked on negotiations of intellectual property issues, regional cooperation, the World Trade Organization’s TRIPS dispute settlement, and domestic policy development. After working with the DFAT, he joined the Australian National University, researching and teaching international intellectual property law. His interests include not only intellectual property and development, but also public health and intellectual property. Professor Taubman’s publications cover a vast range of international intellectual property law and policy issues. He has written a training handbook on intellectual property and biotechnology, as well as authoring such articles as Saving the Village: Conserving Jurisprudential Diversity in the International Protection of Traditional Knowledge and Practical Management of Public-Private Alliances for Public Health Outcomes in the Developing World: The Lessons of Access Conditions in Research and Development Agreements. Professor Taubman currently oversees programs on intellectual property and genetic resources, life sciences, and other global issues in his role with the WIPO.

http://www.wipo.int/academy/en/execed/sipm/chg_jun_07/taubman_bio.html